{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:29:19Z","timestamp":1789216159429,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.eprac.2025.12.005","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:20:29Z","timestamp":1765988429000},"page":"533-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Silent Pheochromocytoma Is an Underrecognized Clinical Entity: Results From a High-Volume Adrenal Surgery Hospital"],"prefix":"10.1016","volume":"32","author":[{"given":"Meredith","family":"LaRue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Kalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7959-9842","authenticated-orcid":false,"given":"Fabio R.","family":"Faucz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Carling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.12.005_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.005_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2025.12.005_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1021420","article-title":"Silent pheochromocytoma and paraganglioma: systematic review and proposed definitions for standardized terminology","volume":"13","author":"Constantinescu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.005_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"Nolting","year":"2022","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.005_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-17-0321","article-title":"Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center","volume":"7","author":"Falhammar","year":"2018","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.005_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/EJE-09-0384","article-title":"Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma","volume":"161","author":"Kopetschke","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.eprac.2025.12.005_bib7","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.12.005_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41574-023-00926-0","article-title":"Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert consensus statement","volume":"20","author":"Taieb","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-01888-y","article-title":"Autonomous cortisol secretion in adrenal incidentalomas","volume":"64","author":"Araujo-Castro","year":"2019","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.005_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3803\/EnM.2017.32.2.152","article-title":"Update on modern management of pheochromocytoma and paraganglioma","volume":"32","author":"Lenders","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.005_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019104","article-title":"Hemodynamic stability during adrenalectomy for pheochromocytoma: a case control study of posterior retroperitoneal vs lateral transperitoneal approaches","volume":"99","author":"Ban","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.005_bib12","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0296","article-title":"Improved and individualized approach to adrenal surgery","volume":"32","author":"Carling","year":"2025","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.005_bib13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jamcollsurg.2021.02.018","article-title":"Contemporary experience of posterior retroperitoneoscopic adrenalectomy in the US","volume":"232","author":"Chiu","year":"2021","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.005_bib14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/wjs.12390","article-title":"Partial adrenalectomy by the posterior retroperitoneoscopic approach: a single institution series of 766 consecutive procedures","volume":"49","author":"Knyazeva","year":"2025","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.005_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12957-023-03164-w","article-title":"Which surgical approach is more favorable for pheochromocytoma of different sizes (< 6 Cm vs. >\/= 6 cm)? A single retrospective center experience","volume":"21","author":"Wan","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.005_bib16","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.eprac.2025.12.005_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/endrev\/bnae001","article-title":"Imaging of pheochromocytomas and paragangliomas","volume":"45","author":"Timmers","year":"2024","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.005_bib18","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1210\/clinem\/dgab698","article-title":"Selective glucocorticoid replacement following unilateral adrenalectomy for hypercortisolism and primary aldosteronism","volume":"107","author":"DeLozier","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.005_bib19","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jc.2018-01707","article-title":"Pheochromocytoma characteristics and behavior differ depending on method of discovery","volume":"104","author":"Gruber","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.005_bib20","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.005_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1210\/clinem\/dgac563","article-title":"Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma","volume":"108","author":"Li","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.005_bib22","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the european network for the study of adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.005_bib23","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.mayocp.2019.03.030","article-title":"Diagnostic accuracy of computed tomography to exclude pheochromocytoma: a systematic review, meta-analysis, and cost analysis","volume":"94","author":"Buitenwerf","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.eprac.2025.12.005_bib24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-024-00984-y","article-title":"Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches","volume":"20","author":"Prete","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.005_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081121","article-title":"Study protocol for a prospective, multicentre study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone","volume":"14","author":"DeFronzo","year":"2024","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.eprac.2025.12.005_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.surg.2015.09.016","article-title":"Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma","volume":"159","author":"Namekawa","year":"2016","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.005_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1210\/clinem\/dgaa794","article-title":"Recurrence rate of sporadic pheochromocytomas after curative adrenalectomy: a systematic review and meta-analysis","volume":"106","author":"Holscher","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.005_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.surg.2022.05.003","article-title":"Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate?","volume":"173","author":"Shirali","year":"2023","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.005_bib29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2025.12.005_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1127676","article-title":"Total versus partial adrenalectomy in bilateral pheochromocytoma - a systematic review and meta-analysis","volume":"14","author":"Zawadzka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:52:18Z","timestamp":1777618338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25013254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1530891X25013254"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.12.005","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silent Pheochromocytoma Is an Underrecognized Clinical Entity: Results From a High-Volume Adrenal Surgery Hospital","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}